NeuroGlympse
NeuroGlympse is dedicated to transforming neurological care through innovative, FDA-cleared digital therapeutics and advanced neurotechnology. They empower legal professionals, patients, and doctors with objective diagnostics, personalized monitoring, and cutting-edge treatments for conditions like concussion, depression, PTSD, anxiety, and more. Their mission is to provide early detection, accurate diagnosis, and comprehensive care to improve patient outcomes and practice growth.
Industries
Nr. of Employees
small (1-50)
NeuroGlympse
Products
Remote therapeutic monitoring platform
A software platform that aggregates wearable and facial PPG data, runs analytic models, and provides clinician dashboards and patient monitoring workflows.
Objective ocular motor diagnostic report (certified report)
A clinician-interpreted report summarizing eye-tracking metrics and objective findings to support mTBI diagnosis and care planning.
Care portal (web dashboard)
A secure web portal enabling appointment requests, access to cases and certified reports, notification settings, and administrative workflows.
Access to prescription digital therapeutics
Provision of FDA-cleared digital therapeutic programs as part of clinical care for insomnia and generalized anxiety disorder.
Remote therapeutic monitoring platform
A software platform that aggregates wearable and facial PPG data, runs analytic models, and provides clinician dashboards and patient monitoring workflows.
Objective ocular motor diagnostic report (certified report)
A clinician-interpreted report summarizing eye-tracking metrics and objective findings to support mTBI diagnosis and care planning.
Care portal (web dashboard)
A secure web portal enabling appointment requests, access to cases and certified reports, notification settings, and administrative workflows.
Access to prescription digital therapeutics
Provision of FDA-cleared digital therapeutic programs as part of clinical care for insomnia and generalized anxiety disorder.
Services
Continuous remote monitoring of physiologic and behavioral biomarkers with periodic clinical review and care-plan adjustments.
Telemedicine consultations with neurology specialists and same-day remote testing to support rapid diagnosis and management.
Preparation of certified reports, letters of medical necessity, and periodic progress notes suitable for clinical and legal use.
Clinical provisioning and integration of FDA-cleared digital therapeutic programs for conditions such as chronic insomnia and generalized anxiety disorder.
Patient education, device facilitation, referral, and support for vagus nerve stimulation and transcranial magnetic stimulation therapies.
Continuous remote monitoring of physiologic and behavioral biomarkers with periodic clinical review and care-plan adjustments.
Telemedicine consultations with neurology specialists and same-day remote testing to support rapid diagnosis and management.
Preparation of certified reports, letters of medical necessity, and periodic progress notes suitable for clinical and legal use.
Clinical provisioning and integration of FDA-cleared digital therapeutic programs for conditions such as chronic insomnia and generalized anxiety disorder.
Patient education, device facilitation, referral, and support for vagus nerve stimulation and transcranial magnetic stimulation therapies.
Expertise Areas
- Remote therapeutic monitoring
- mTBI and concussion diagnostics
- TeleNeurology and telemedicine workflows
- Neuromodulation therapy coordination (VNS, TMS)
Key Technologies
- Facial photoplethysmography (facial PPG)
- Eye-tracking / ocular motor analysis
- Deep neural networks / machine learning
- Wearable biometric sensors
News & Updates
Join the Revolution in Brain Health
Neuroglympse invites healthcare providers to implement their platform for early detection and improved patient outcomes.
A YouTube video sharing the story of the company's founder and their mission to innovate neurological care.
FDA Clearance for Digital Therapeutics
Neuroglympse's SleepioRx and DaylightRx are FDA-cleared for insomnia and GAD, respectively, backed by extensive clinical research.
Innovative Neurodiagnostic Technology
Development of industry-first neuromonitoring and objective assessment tools for mTBI and neurological conditions.
Research and Publications
Contributions to medical journals and scientific literature on neurodiagnostics and treatment.
Join the Revolution in Brain Health
Neuroglympse invites healthcare providers to implement their platform for early detection and improved patient outcomes.
A YouTube video sharing the story of the company's founder and their mission to innovate neurological care.
FDA Clearance for Digital Therapeutics
Neuroglympse's SleepioRx and DaylightRx are FDA-cleared for insomnia and GAD, respectively, backed by extensive clinical research.
Innovative Neurodiagnostic Technology
Development of industry-first neuromonitoring and objective assessment tools for mTBI and neurological conditions.
Research and Publications
Contributions to medical journals and scientific literature on neurodiagnostics and treatment.